YMAB
Y-mAbs Therapeutics
YMAB
YMAB
Delisted
YMAB was delisted on the 15th of September, 2025.
97 hedge funds and large institutions have $394M invested in Y-mAbs Therapeutics in 2021 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 38 increasing their positions, 28 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
1.25% less ownership
Funds ownership: 60.22% → 58.97% (-1.3%)
45% less capital invested
Capital invested by funds: $716M → $394M (-$322M)
Holders
97
Holding in Top 10
2
Calls
–
Puts
–
Top Buyers
| 1 | +$8.5M | |
| 2 | +$4.05M | |
| 3 | +$3.34M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$2.02M |
| 5 |
Renaissance Technologies
New York
|
+$1.6M |
Top Sellers
| 1 | -$16.5M | |
| 2 | -$9.66M | |
| 3 | -$9.01M | |
| 4 |
BC
Brookfield Corp
Toronto,
Ontario, Canada
|
-$5.12M |
| 5 |
ACM
Ashford Capital Management
Wilmington,
Delaware
|
-$3.66M |